Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma

NCT04156828 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Terminated due to low accrual

Conditions

Grade 3b Follicular Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma
Recurrent Follicular Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma

Interventions

DRUG: Copanlisib
DRUG: Gemcitabine
DRUG: Carboplatin
DRUG: Dexamethasone
BIOLOGICAL: Rituximab
BIOLOGICAL: Pegfilgrastim

Sponsor

University of Washington

Collaborators

[object Object]